Palisade Bio

$PALI is leading the Prism MarketView Biotech index and is up over 100% currently after the company announced it has decided to cancel a proposed $5 million offering and possibly enact a reverse split.

Share this article:

About the Author:

Palisade Bio

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup